[Non-infiltrating breast cancers]

We have taken stock about incidence, diagnostic problems, anatomic-pathological features, prognosis and treatment of non-infiltrating breast cancers, that are the lobular cancer in situ (LICS), and the duct cancer in situ (DCIS). It's been pointed out the shortage of specific aspect into the images diagnostics for LICS; besides it's been pointed out the control to keep for these kinds of tumor, that has to be of preservative type ("wait and see"). About DCIS, we have showed some still open problems, especially the difficulty in finding a prognostic criterion about the evolution of the disease forward invasive forms. It follows that there is the difficulty in defining a real treatment that should reconcile the presence of a non-invasive damage with the need of guaranteeing the recovery. In the age of preservative treatments of invasive forms, mastectomy (that is still often carried out), could seem to be an overtreatment, so we've showed the studies results, which could let us think that a preservative treatment, joined to the radiotherapy, could be really preferred.